22 May 2018 | 3:54 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
756.95
-6.35
(-0.83 %)
22 May 2018 | 03:39 PM
Change company
  • Open (Rs)
    779.95
  • Prev. close (Rs.)
    763.30
  • High (Rs.)
    781.00
  • Low (Rs.)
    754.00
  • 52W H (Rs.)
    1,080.00
  • 52W L (Rs.)
    671.25
  • Volume
    14361
  • MCap (Rs in Cr.)
    13,965.20
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
27.88
Operating Margin (%)
33.82
Gross Profit Margin (%)
31.13
Net Profit Margin (%)
24.05
Total Debt/Equity
0.13
Dividend payout Ratio (Net Profit)
29.13
Earning Retention Ratio
70.80

News

05 Apr 2018 - 09:23:00-Leading pharma major Natco Pharma Limited has said that it is the first company in India to launch a...
19 Feb 2018 - 11:01:00-Leading pharma major Natco Pharma Limited has said that there has been a successful completion of re...
19 Feb 2018 - 11:01:00-Leading pharma major Natco Pharma Limited has said that there has been a successful completion of re...
06 Feb 2018 - 15:32:00-Drug firm Natco Pharma today reported a 11...

Announcements

21-May-2018
Natco Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
21-May-2018
Natco Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-May-2018
Natco Pharma - Board Meeting To Be Held On May 23 2018
16-May-2018
Natco Pharma - Trading Window
30-Apr-2018
Natco Pharma - Reg 40(10) PCS Certificate

Religare Research

22 May 2018 | 11:07 AM
Highlights: • Normal Monsoon and its early arrival predictions by the IMD kept pressure on the...
22 May 2018 | 10:26 AM
DTF
22 May 2018 | 10:15 AM
The rupee ended at 68.12 to a dollar, lowest since Jan. 24, 2017, against 68.01 at the previous clos...
22 May 2018 | 10:15 AM
TeamLease Services (TEAM) reported robust set of numbers wherein Net sales grew by 19.6% in line wit...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 28.88 -1.30
4,00,000 90.05 139.53 -1.29
4,00,000 90.05 147.11 -1.28
4,00,000 90.05 49.39 -1.30
1,60,000 35.89 69.58 -2.70

Shareholding Pattern

       
Promotors48.38%
Mutual Funds/UTI5.67%
FI/Banks0.65%
Insurance0.65%
FII23.96%
Government0.00%
Others3.60%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
6,521.10(-1.91)
3280
 Sanofi India Ltd.
4,920.40(-0.42)
3325
 GlaxoSmithKline Pharmaceuticals Ltd.
2,436.95(2.90)
3317
 Pfizer Ltd.
2,400.00(0.44)
3370

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.-53.95-19.95-147.15
NIFTY(S&P CNX)-48.00139.25209.80
BSE SENSEX200.47806.381,172.89
BSE 500-343.96-2.68-26.85

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar